With a new cloud-based tool dubbed HIVE, the US Food and Drug Administration is readying itself for the onslaught of next-generation sequencing data that will soon be included in many regulatory submissions, the FDA Voice blog says.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Highs and Lows

Genomics' Hot Streak

Sorta Safe and Secure

Too Slow or Too Fast

Scaling up Biodefense

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.